Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?

Abstract:

BACKGROUND:We analyzed renal cell carcinoma (RCC) brain metastasis (BM) risk factors and compared BM occurrence in metastatic RCC (mRCC) treated with or without anti-angiogenic agents (AA). METHODS:Data from all consecutive metastatic RCC patients (patients) treated in a french cancer center between 1995 and 2008 were reviewed. Patients had histologically confirmed advanced RCC without synchronous BM at the time of metastasis diagnosis. AA were sorafenib, sunitinib and bevacizumab. We also included patients treated with mTor inhibitors, temsirolimus and everolimus, as they also demonstrated anti-angiogenic activities. Characteristics of the two groups treated with or without AA were compared with a Fisher exact test. Impact of AA on overall survival (OS) and cumulative rate of brain metastasis (CRBM) was explored by Kaplan-Meier method. RESULTS:One hundred and ninety-nine patients with advanced RCC were identified, 51 treated with AA and 148 without AA. The median follow-up duration was 40 months. BM occurred in 35 patients. Characteristics between AA treated and non-AA treated groups were unbalanced and favoring better prognostic factors in AA treated group. Median OS was 24 months. AA treatment was not associated with a lower CRBM (HR = 0.58 [0.26-1.30], P = 0.187). Median survival free of BM was 11.8 months, CI95% (4.95-18.65) in the group without AA treatment and 28.9 months in the AA group, CI95% (18.64-39.16). Alkaline phosphatase (AP) was an independent prognostic factor for BM (P = 0.05). In multivariate Cox model, after adjustment to AP, AA did not improve the CRBM (aHR = 0.53 [0.22-1.32]). CONCLUSION:In this retrospective study, AA did not decrease significantly the CRBM. Elevated AP was a predictive factor for BM in mRCC.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Vanhuyse M,Penel N,Caty A,Fumagalli I,Alt M,Zini L,Adenis A

doi

10.1684/bdc.2012.1672

subject

Has Abstract

pub_date

2012-12-01 00:00:00

pages

100-6

issue

12

eissn

0007-4551

issn

1769-6917

pii

bdc.2012.1672

journal_volume

99

pub_type

杂志文章
  • [Esophageal cancer in Western France. Retrospective analysis of 1400 cases].

    abstract::A retrospective review was made of 1 400 cases of cancer of the esophagus treated at the Centre "Francois Baclesse" between 1964 and 1975. The disease appeared at an earlier age and more frequently in men (95%) than in women. The lesions were located predominantly in the middle third of the esophagus. There was a high...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Roussel A,Gignoux M,Verwaerde JC,Segol P,Abbatucci JS,Valla A

    更新日期:1977-01-01 00:00:00

  • [Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method].

    abstract::Estrogen receptor determinations were performed on 241 cytosols from 160 breast cancer tumors, using both dextran coated charcoal method (D.C.C.) and monoclonal antibodies (Abbott's ER-EIA kit) in order to compare the two methods, and to evaluate the clinical usefulness of this new immunological simplified assay. Intr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J,Lechevrel C,Martin PM,Roussel G

    更新日期:1985-01-01 00:00:00

  • [Marital communication and depressive symptoms in couples in which the woman has cancer of the breast].

    abstract::If doctor-patient communication is a frequent subject of research, couples communication where one partner has cancer is quite recent. Some studies deal with couples communication, but from an anecdotic perspective, without any operational measure. The aim of this paper is to study couples' communication frequency and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Normand J,Lasry JC,Margolese RG,Perry JC,Fleiszer D

    更新日期:2004-02-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Mechanisms and role of lymphangiogenesis in cancer metastasis].

    abstract::An important critical point in tumor progression is the acquisition of metastatic potential. The presence of metastases in regional lymph nodes is an indicator of poor survival. The vascular endothelial growth factor (VEGF) family of growth factors and receptors is involved in vasculogenesis and angiogenesis. Among th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dupuy E,Tobelem G

    更新日期:2003-07-01 00:00:00

  • [Prognostic factors in endometrial cancer: apropos of 206 cases treated at the Curie Institute].

    abstract::From January 1, 1983 to December 31, 1990 two hundred and six patients with an invasive, non metastatic endometrial carcinoma were first treated at Institut Curie. Initial tumoral staging (TNM) was as follows: stage Ia: 48%, stage Ib: 31%, stage II: 15% and stage III-IV: 6%. Total hysterectomy or colpohysterectomy was...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chen Q,de la Rochefordière A,Mouret-Fourme E,Durand JC,Clough K,Asselain B,Labib A,Fenton J

    更新日期:1995-09-01 00:00:00

  • [Cured after an intraocular tumor].

    abstract::We describe the psychological reactions after diagnosis and treatment of the malignant intraocular tumors: uveal melanoma and retinoblastoma. The chapter on uveal melanoma includes general consideration on the treatment of these tumors, the psychological effects on the patients, the professional and social problems, t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Desjardins L,Delage M,Lumbroso L,Levy C,Doz F

    更新日期:2001-11-01 00:00:00

  • [Epidemiology of HIV-associated malignancies].

    abstract::Human immunodeficiency virus (HIV)-associated malignancies include acquired immunodeficiency virus: Aids-defining malignancies, Kaposi's sarcoma, (KS), non-Hodgkin's lymphoma (NHL), and, since 1993, invasive cervical cancer (1CC), and non-Aids defining malignancies. Most cancers that are associated with HIV infection ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Launay O,Guillevin L

    更新日期:2003-05-01 00:00:00

  • [Changes in methylation of tumor cells: a new in situ quantitative approach on interphase nuclei and chromosomes].

    abstract::DNA methylation is known to be related to the regulation of gene expression. DNA methylation patterns are modified in tumors compared to normal tissue, and in some cases, these variations are linked to cancer progression. Molecular biology techniques are generally used to evaluate DNA methylation status. We describe h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Veilleux C,Bernardino J,Gibaud A,Niveleau A,Malfoy B,Dutrillaux B,Bourgeois CA

    更新日期:1995-11-01 00:00:00

  • [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2017.10.017

    authors: Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

    更新日期:2017-12-01 00:00:00

  • Immunothérapie des glioblastomes.

    abstract:IMMUNOTHERAPY IN GLIOBLASTOMAS:Targeting the immune system as a therapeutic strategy in solid tumors has shown great efficacy in various tumor types. However the role and success of this approach in glioblastomas remain to be determined. Recent studies demonstrated that central nervous system is no longer considered as...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(18)30391-6

    authors: Baldini C,Romano PM,Varga A,Champiat S,Dumont S,Dhermain F,Louvel G,Marabelle A,Postel-Vinay S,Angevin E,Gazzah A,Ribrag V,Bahleda R,Michot JM,Hollebecque A,Soria JC,Massard C

    更新日期:2018-12-01 00:00:00

  • ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

    abstract:INTRODUCTION:Genetic predisposition to familial hematological malignancies was previously described through several epidemiological analyses, but the genetic basis remains unclear. The tumor-suppressor ARLTS1 gene was previously described in sporadic hematological malignancies and familial cancer context. METHODS:In t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.10.016

    authors: Hamadou WS,Besbes S,Mani R,Bourdon V,Ben Youssef Y,Achour B,Regaieg H,Eisinger F,Mari V,Gesta P,Dreyfus H,Bonadona V,Dugast C,Zattara H,Faivre L,Noguchi T,Khélif A,Sobol H,Soua Z

    更新日期:2017-02-01 00:00:00

  • [Communication process in consultation of patients with incurable disease: a prospective study].

    abstract::Patients wish to be fully informed about their health, but some information and its disclosure may pose special challenges depending on the severity of the illness. This prospective observational study investigates the content of information about the disease and treatment, as well as the process by which information ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1530

    authors: Marcoux I

    更新日期:2012-02-01 00:00:00

  • [Treatment of mucositis pain: News and prospects].

    abstract::Mucositis, an acute inflammation of the digestive mucosa, is one of the main toxicities secondary to oncological treatments. Among its consequences, mucositis-related pain is an important complication due to its intensity and repercussion, especially on quality of life. Treatment of pain plays a central role in manage...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2019.03.022

    authors: Guerrini-Rousseau L,Marec-Berard P,Bolle S,Laurent S

    更新日期:2019-09-01 00:00:00

  • [BCG therapy of superficial tumors of the bladder].

    abstract::Superficial bladder tumor defined as pTa, pT1 and pTis stage is one of the most common cancer disease in the world. Intravesical BCGtherapy represents the best treatment when combined with transurethral resection to prevent tumor recurrence or progression and to lengthen the interval between recurrence. The toxicity i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Prapotnich D

    更新日期:1998-02-01 00:00:00

  • Targeting DNA methylation in cancer.

    abstract::Cancer growth and metastasis require the coordinate change in gene expression of different sets of genes. While genetic alterations can account for some of these changes, many of the changes in gene expression observed in cancer are caused by epigenetic modifications. The epigenome consists of the chromatin and its mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Szyf M

    更新日期:2006-09-01 00:00:00

  • [Identification of basal-like carcinomas in clinical practice: "triple zero/BRCA1-like" carcinomas].

    abstract::Basal-like carcinomas represent 10 to 15% of invasive breast carcinomas and have been identified from gene expression studies. Morphologically, these tumors are undifferentiated histopronostic grade 3 carcinomas, identified in clinical practice according to their immunophenotype "triple zero" (estrogen, progesterone a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1062

    authors: Vincent-Salomon A,Macgrogan G,Charaffe-Jauffret E,Jacquemier J,Arnould L

    更新日期:2010-03-01 00:00:00

  • Quality of care assessment for breast cancer: how to measure benefits of prevention and therapy in oncology.

    abstract::Over the last few years evaluation of quality of diagnostic and therapeutic care has become one of the most controversial and fastest growing fields of research in many areas of medicine. In this situation, oncology represents a model case as the conditions in which new therapeutic strategies are tested and implemente...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Liberati A,Fossati R,Torri W

    更新日期:1987-01-01 00:00:00

  • [Supportive care for survivors].

    abstract::Advances in early detection and treatment have pushed in a few decades the management of cancers from a management model of the end of life to the management of a chronic disease. This evolution has accelerated the development of supportive care in two directions, firstly towards the best possible support to the end o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.007

    authors: Ninot G,Debourdeau P,Blanc-Legier F,De Crozals F,De Rauglaudre G,Khouri S,Kirscher S,Mineur L,Piollet I,Sant I,Schillinger P,Serin D

    更新日期:2018-09-01 00:00:00

  • [Blood amylase: a biological marker in irradiation accidents? Preliminary results obtained at the Gustave-Roussy Institut (GRI) and a literature review].

    abstract::The retrospective evaluation of the dose after an irradiation accident is of paramount importance; it allows an adequate selection of patients and the most appropriate treatment can then be proposed. Classical physical dosimetry often lacks precision for dose assessment in such accidents. Cytogenetics, usually more re...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hennequin C,Cosset JM,Cailleux PE,Girinsky T,Ganem G,Hubert D,Comoy E,Dutreix J

    更新日期:1989-01-01 00:00:00

  • [Experimental program personalized care in patients with head and neck cancer].

    abstract:OBJECTIVE:Describe the implementation and preliminary results of the “Experimental Program Personalized care” in patients with Head and Neck cancer. MATERIALS AND METHODS:After being selected a graduate nurse status, called coordination, participated in the development of forms of detection needs and concerns of patie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.2040

    authors: Hans S,Scotte F,Hoffman C,Pelicier N,Ménard M,Badoual C,Oudard S,Housset M,Brasnu D

    更新日期:2014-10-01 00:00:00

  • [Primary cerebral tumors in children. II: Topography and treatment].

    abstract::In part I of this article, we reviewed the general aspects of childhood brain tumors. In part II, we present the most common neoplasms and their treatment. The quality of the surgical resection appears to be of first importance in the prognosis. Progress in radiotherapy and chemotherapy have contributed to the improve...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Carrie C,Bouffet E,Brunat-Mentigny M,Philip T,Lacroze M

    更新日期:1989-01-01 00:00:00

  • Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.

    abstract:OBJECTIVE:The purpose of this study was to explore the risk factors that were associated with central lymph node metastasis (CLNM) in patients with clinical nodal negative differentiated thyroid carcinoma (cN0 DTC) after prophylactic central neck dissection (pCND). The influence of pCND on TNM staging and recurrence ri...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.04.003

    authors: Lin X,Chen X,Jiru Y,Du J,Zhao G,Wu Z

    更新日期:2016-06-01 00:00:00

  • [End of chemotherapy decision for metastatic breast cancer patients.].

    abstract::If chemotherapy beyond the third line often gives sum clinical benefits, it is sometimes prescribed only to avoid telling bad news to patients. Palliative chemotherapy can lead to symptom reduction and greater health related quality-of-live, but longer survival is unlikely. Physician's questioning about chemotherapy c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0895

    authors: Bouleuc C,Chvetzoff G

    更新日期:2009-09-01 00:00:00

  • [Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting].

    abstract::The anticancer drug technical commission (COTECH) of the Auvergne OMEDIT has set up a region-wide professional practice evaluation (PPE) with regards to antiemetic prescription practices in chemotherapy-induced nausea and vomiting (CINV), in order to evaluate their compliance with OMEDIT's guidelines. Are not included...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.009

    authors: Tavernier J,Jouannet-Romaszko M,Bertucat H,Marchiset N,Bahadoor M,Chevrier R

    更新日期:2016-07-01 00:00:00

  • [Cyclooxygenase 2 inhibitors and cancer chemoprevention].

    abstract::Chemoprevention is the use of natural or synthetic compounds in order to reverse, suppress or prevent the carcinogenic process. Among the many pathways dysregulated during the carcinogenic process, cyclooxygenase-2 (Cox2) seems to be one of the most promising pathways to target in order to achieve chemopreventive and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Masmoudi A,Chevalier TL,Sabatier L,Soria JC

    更新日期:2004-05-01 00:00:00

  • [Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates].

    abstract::Compared with other breast cancer subtypes, patients with metastatic triple-negative breast cancer (TNBC) are younger and have a worst overall survival with a median of 15 to 18 months. These tumors have long suffered from a purely negative definition, but the last few years have witnessed many breakthrough genomic an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.11.007

    authors: Dalenc F,Sarradin V,Nicolaï V,Franchet C,Ung M

    更新日期:2021-01-01 00:00:00

  • [Nab-paclitaxel].

    abstract::Paclitaxel is conventionally used in a wide range of oncology indications. Nab-paclitaxel is synthesized by a process of high pressure homogenization of paclitaxel in the presence of human albumin and it was originally developed to reduce the toxicity usually associated with cremophor in soluble paclitaxel and to incr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.020

    authors: Lopez-Trabada Ataz D,Dumont S,André T

    更新日期:2015-06-01 00:00:00

  • [Biology of small-cell bronchogenic carcinoma: recent advances].

    abstract::In the last ten years considerable progress has been made in small-cell lung carcinoma (SCLC) biology, along with the technical progress made in molecular biology. This progress now allows us to propose a model for the genesis and the development of this type of tumor. Tobacco, the principal causal factor plays a dual...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Levy R,Andrieu JM,Even P

    更新日期:1992-01-01 00:00:00

  • A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

    abstract::Twenty-eight patients with poor prognosis, advanced metastatic non seminomatous germ cell tumors (NSGCT) were treated with early high dose chemotherapy and autologous bone marrow transplantation (ABMT) rescue. The primary tumor was testicular in 19 patients and extragonadal in nine patients. For 19 patients with a tes...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Droz JP,Pico JL,Ghosn M,Kramar A,Rey A,Ostronoff M,Baume D

    更新日期:1992-01-01 00:00:00